Background The importance of heart failure with preserved ejection fraction is increasingly
recognized. We conducted a study to evaluate the epidemiologic features and outcomes of …

ContextA predictive model of mortality in heart failure may be useful for clinicians to improve
communication with and care of hospitalized patients.ObjectivesTo identify predictors of …

The coronavirus disease 2019 (COVID-19) pandemic has affected health and economy
worldwide on an unprecedented scale. Patients have diverse clinical outcomes, but those with …

Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin
II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 (…

Background The prognosis of patients with homozygous β-thalassemia (thalassemia major)
has been improved by transfusion and iron-chelation therapy. We analyzed outcome and …

Natriuretic peptide (NP) levels (B‐type natriuretic peptide (BNP) and N‐terminal proBNP) are
now widely used in clinical practice and cardiovascular research throughout the world and …

Statins are lipid-lowering therapeutics with favorable anti-inflammatory profiles and have
been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk of …

Background—Continuous positive airway pressure (CPAP) improves cardiac function in
patients with congestive heart failure (CHF) who also have Cheyne-Stokes respiration and …

Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic
dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; …

In mammalian cells, CAR coreceptors determine efficiency in host cell targeting by coxsackie
and adenoviruses. Coxsackievirus B (CVB) utilizes the complement deflecting protein …